February 14, 2023 02:54 PM ESTUpdated 06:00 PM

Law experts argue that abortion drug withdrawal would 'undermine' the approval process

Nicole DeFeudis

Editor

More than a dozen food and drug law experts argued on Wednesday that yanking the medication abortion drug mifepristone from the market would “undermine the …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Law experts argue that abortion drug withdrawal would 'undermine' the approval process

Nicole DeFeudis

Editor

Sign up to read this article for free.

Sr. Manager/Associate Director, Document Control

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

Law ex­perts ar­gue that abor­tion drug with­draw­al would 'un­der­mine' the ap­proval process

Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

Law experts argue that abortion drug withdrawal would 'undermine' the approval process